Home - Products - MAPK/ERK Signaling - p38 MAPK - Ro-3201195

Ro-3201195

CAS No. 249937-52-8

Ro-3201195( —— )

Catalog No. M36218 CAS No. 249937-52-8

Ro-3201195 is a novel orally available p38 MAPK inhibitor with high selectivity.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
2MG	198	Get Quote
5MG	304	Get Quote
10MG	456	Get Quote
25MG	723	Get Quote
50MG	994	Get Quote
100MG	1332	Get Quote
500MG	2664	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Ro-3201195
Note

Research use only, not for human use.
Brief Description

Ro-3201195 is a novel orally available p38 MAPK inhibitor with high selectivity.
Description

Ro-3201195 is a novel orally available p38 MAPK inhibitor with high selectivity.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

MAPK/ERK Signaling
Target

p38 MAPK
Recptor

p38 MAPK
Research Area

——
Indication

——

Chemical Information

CAS Number

249937-52-8
Formula Weight

371.36
Molecular Formula

C19H18FN3O4
Purity

>98% (HPLC)
Solubility

——
SMILES

NC=1N(N=CC1C(=O)C2=CC(OCC(CO)O)=CC=C2)C3=CC=C(F)C=C3
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

dencichine

Dencichine is a neurotoxic agent. Dencichine is a haemostatic agent, the hemostatic effect relates to modulation of the coagulation system, platelet aggregation and fibrinolytic system.
TAK-715

A potent, selective, orally active p38α MAPK inhibitor with IC50 of 7.1 nM.
MAPK13-IN-1

MAPK13-IN-1 is a potent MAPK13 (p38δ) inhibitor (IC50: 620 nM).

Sign In Join Free